Ponte Carmen, Parra Araceli, Cenjor Carlos, Garcia-Olmos Marta, Gimenez Maria Jose, Aguilar Lorenzo, Carcas Antonio, Soriano Francisco
Department of Medical Microbiology, Fundación Jiménez Díaz, 28040 Madrid, Spain.
Pediatr Res. 2003 Dec;54(6):913-8. doi: 10.1203/01.PDR.0000090931.94785.DA. Epub 2003 Aug 20.
The possible interference of acetaminophen, combined with antibiotics, in the treatment of acute otitis media (AOM) caused by a penicillin-resistant (minimal inhibitory concentration [MIC], 2 microg/mL), amoxicillin/clavulanic acid- and erythromycin-sensitive pneumococcus was evaluated in a gerbil model. Animals were challenged with approximately 5 x 106 bacteria in each ear through transbullar instillation. Acetaminophen was administered s.c. at 50 mg/kg 30 min before each antibiotic dose. Amoxicillin/clavulanic acid and erythromycin (2.5 and 10 mg/kg) were administered s.c. at 2, 10, and 18 h after inoculation. Samples were obtained from the middle ear (ME) on day 2 after inoculation for bacterial count. The overall results showed no difference between animals that received acetaminophen, with or without antibiotics, and those that did not receive acetaminophen. The antibiotic concentrations in the ME were practically identical in both groups of animals, so acetaminophen did not interfere with the pharmacokinetics of antibiotics in the ME. However, both antibiotics significantly reduced the number of culture-positive and the bacterial concentration in ME samples when compared with antibiotic-untreated animals. Both antibiotics, whether combined with acetaminophen or not, lowered the number of AOM to <25%, but >75% of animals presented otitis media with effusion, and no differences were shown between groups. A high rate of bacterial eradication from the ME correlated with antibiotic serum concentrations being over the MIC of the infecting organism for only >15% of the dose interval and with an ME concentration exceeding the MIC by a factor of 1.7. In this experimental model, acetaminophen had neither a synergistic nor an antagonistic effect on the antibiotics tested.
在沙鼠模型中评估了对乙酰氨基酚与抗生素联合使用时,对由耐青霉素(最低抑菌浓度[MIC],2微克/毫升)、对阿莫西林/克拉维酸和红霉素敏感的肺炎球菌引起的急性中耳炎(AOM)治疗的可能干扰。通过经鼓室滴注,在每只耳朵中用约5×10⁶个细菌对动物进行攻击。在每次给予抗生素前30分钟,以50毫克/千克的剂量皮下注射对乙酰氨基酚。接种后2、10和18小时,皮下注射阿莫西林/克拉维酸和红霉素(2.5和10毫克/千克)。接种后第2天从中耳(ME)获取样本进行细菌计数。总体结果显示,接受对乙酰氨基酚(无论是否联合使用抗生素)的动物与未接受对乙酰氨基酚的动物之间没有差异。两组动物中耳中的抗生素浓度实际上是相同的,因此对乙酰氨基酚不会干扰抗生素在中耳中的药代动力学。然而,与未用抗生素治疗的动物相比,两种抗生素均显著降低了ME样本中培养阳性的数量和细菌浓度。两种抗生素,无论是否与对乙酰氨基酚联合使用,都将AOM的数量降低至<25%,但>75%的动物出现了中耳积液,且各组之间未显示出差异。从中耳的高细菌清除率与抗生素血清浓度仅在>15%的剂量间隔内超过感染生物体的MIC以及中耳浓度超过MIC 1.7倍相关。在这个实验模型中,对乙酰氨基酚对所测试的抗生素既没有协同作用也没有拮抗作用。